#dividend aristocrat

2개의 글

May 8, 2026

ABT Abbott Stock Outlook 2026: FreeStyle Libre's CGM Moat Is Widening While Dexcom Struggles

Abbott Laboratories (ABT) stock outlook 2026. FreeStyle Libre CGM dominance, 4-segment diversification, 52-year dividend streak, 50% analyst upside, and price target scenarios for US investors.

ABT Abbott FreeStyle Libre

May 8, 2026

ABBV AbbVie Stock Outlook 2026: Skyrizi and Rinvoq Prove the Humira Replacement Was Real

AbbVie (ABBV) stock outlook 2026. Humira biosimilar erosion absorbed, Skyrizi+Rinvoq now exceeding peak Humira combined, 3.41% dividend yield, 12-month price target scenarios analyzed.

ABBV AbbVie dividend aristocrat